Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Other Non Operating Income (2020 - 2025)

Historic Other Non Operating Income for Maravai Lifesciences Holdings (MRVI) over the last 6 years, with Q3 2025 value amounting to -$71000.0.

  • Maravai Lifesciences Holdings' Other Non Operating Income fell 19861.11% to -$71000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.9 million, marking a year-over-year decrease of 11036.4%. This contributed to the annual value of -$3.2 million for FY2024, which is 13836.95% down from last year.
  • According to the latest figures from Q3 2025, Maravai Lifesciences Holdings' Other Non Operating Income is -$71000.0, which was down 19861.11% from -$4.1 million recorded in Q2 2025.
  • Maravai Lifesciences Holdings' Other Non Operating Income's 5-year high stood at $914000.0 during Q4 2022, with a 5-year trough of -$4.1 million in Q2 2025.
  • Moreover, its 5-year median value for Other Non Operating Income was $3000.0 (2021), whereas its average is -$469842.1.
  • In the last 5 years, Maravai Lifesciences Holdings' Other Non Operating Income crashed by 4240000.0% in 2022 and then surged by 175000.0% in 2023.
  • Over the past 5 years, Maravai Lifesciences Holdings' Other Non Operating Income (Quarter) stood at $201000.0 in 2021, then surged by 354.73% to $914000.0 in 2022, then plummeted by 94.64% to $49000.0 in 2023, then tumbled by 1738.78% to -$803000.0 in 2024, then skyrocketed by 91.16% to -$71000.0 in 2025.
  • Its last three reported values are -$71000.0 in Q3 2025, -$4.1 million for Q2 2025, and $24000.0 during Q1 2025.